Ted Knous
Director/Board Member at University of Kansas
Ted Knous active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of Kansas | Director/Board Member | 2009-03-30 | - |
Career history of Ted Knous
Former positions of Ted Knous
| Companies | Position | Start | End |
|---|---|---|---|
Igxbio, Inc.
 Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Director/Board Member | 2009-03-30 | - |
Training of Ted Knous
| University of Minnesota | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Health Technology |
- Stock Market
- Insiders
- Ted Knous
- Experience
